Brain abscess following solid organ transplantation: A 21‐year retrospective study
- 13 October 2024
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 26 (6) , e14394
Abstract
Background: Development of brain abscess following solid organ transplantation is associated with significant morbidity and mortality. We undertook a descriptive study to evaluate the etiology, clinical manifestations, diagnosis, management, and outcomes of brain abscess in solid organ transplant (SOT) recipients at three major transplant centers in the United States.Methods: This is a retrospective study of adults with brain abscess following SOT between January 2000 and June 2021 at Mayo Clinic sites in Arizona, Minnesota, and Florida.Results: A total of 39 patients were diagnosed with a brain abscess following SOT. The most common pathogens were Nocardia sp. (24 cases, 61.5% [Nocardia farcinica, 37.5%]), followed by fungi (12 cases, 30.7% [Aspergillus sp., 83.3%]). The majority were kidney transplant recipients (59%). Median time to brain abscess diagnosis was 1.3 years (range, 29 days–12 years) after SOT; 10 of 12 patients (83%) with fungal brain abscess were diagnosed within 1 year after SOT. Twelve patients underwent brain biopsy for diagnosis (25% Nocardia vs. 50% fungal), eight (20.5%) underwent surgical resection of the abscess, and 31 (79.5%) received antimicrobial therapy alone. Median time to brain abscess resolution was 166 days for Nocardia and 356 days for fungal pathogens. Eleven of 39 patients (28.2%) died as a result of their brain abscess, including four of 24 patients (16%) with Nocardia and six of 10 patients (60%) with Aspergillus brain abscess. All‐cause mortality was 43.6%.Conclusion: Brain abscess remains an uncommon infectious complication following SOT. Nocardia and fungi accounted for 92% of pathogens in our cohort. Fungal brain abscess portends a poor prognosis. imageKeywords
This publication has 26 references indexed in Scilit:
- Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysisClinical Microbiology and Infection, 2023
- European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adultsClinical Microbiology and Infection, 2023
- Invasive fungal infection of the brain caused by Neoscytalidium dimidiatum in a post-renal transplant patient: A case reportMedical Mycology Case Reports, 2021
- Invasive Nocardiosis in Transplant and Nontransplant Patients: 20-Year Experience in a Tertiary Care CenterMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2021
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research ConsortiumThe Lancet Infectious Diseases, 2019
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guidelineClinical Microbiology and Infection, 2018
- Fungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical features*Clinical Transplantation, 2002
- Cerebral infection with Rhodococcus equi in a heart transplant recipientThe Journal of Heart and Lung Transplantation, 2002
- Brain abscess in renal transplant recipients: Report of three casesSurgical Neurology, 1997
- Brain Abscess in Solid Organ Transplant Recipients Receiving Cyclosporine-Based ImmunosuppressionArchives of Surgery, 1997